Medicenna Therapeutics: Funding, Investors & Team (Sep 2026)
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and commercialization of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines (ECs) for the treatment of a broad range of cancers. Its proprietary technology platform supports a unique, multi-methodology treatment paradigm that can precisely deliver potent cell-killing agents for cancer as well as actively alter the immunosuppressive tumor micro-environment without harming healthy cells. The company was founded in 2012 and based in Toronto, Ontario, Canada.
Medicenna Therapeutics has raised $24.4M across 2 funding rounds on record, the most recent an undisclosed round of $4.4M announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Medicenna Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Medicenna Therapeutics Funding Rounds
Medicenna Therapeutics raised $20.0M in a Post-IPO Equity announced in Aug 2022.
3.8 years later, an undisclosed round of $4.4M was announced in Jun 2026.
Medicenna Therapeutics Founders and Leadership Team
Contact details for the Medicenna Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Medicenna Therapeutics Funding Compared to Other Biotechnology Startups
Medicenna Therapeutics' latest round of $4.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Medicenna Therapeutics in Biotechnology and Toronto
Companies Similar to Medicenna Therapeutics
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Resverlogix Corporation, a biopharmaceutical company, focuses on the development of novel therapeutics in…
Medicenna Therapeutics Funding FAQs
What does Medicenna Therapeutics do?
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and commercialization of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines (ECs) for the treatment of a broad range of cancers. Its proprietary technology platform supports a unique, multi-methodology treatment paradigm that can precisely deliver potent cell-killing agents for cancer as well as actively alter the immunosuppressive tumor micro-environment without harming healthy cells. The company was founded in 2012 and based in Toronto, Ontario, Canada.
How much funding has Medicenna Therapeutics raised?
Medicenna Therapeutics has raised $24.4M across 2 rounds on record. The most recent is an undisclosed round of $4.4M announced in Jun 2026.
When did Medicenna Therapeutics last raise funding?
Medicenna Therapeutics' most recent funding round on record is an undisclosed round of $4.4M, announced in Jun 2026.
Who is the CEO of Medicenna Therapeutics?
Fahar Merchant is listed as CEO at Medicenna Therapeutics.
Where is Medicenna Therapeutics headquartered?
Medicenna Therapeutics is based in Toronto, Ontario, Canada.
How many employees does Medicenna Therapeutics have?
Medicenna Therapeutics is in the 11-50 employee band.
How does Medicenna Therapeutics' funding compare to other Biotechnology startups?
Medicenna Therapeutics' latest round of $4.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Medicenna Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Medicenna Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.